Galocitabine
Alternative Names: Neofrutulon; RO 091390Latest Information Update: 07 Mar 2007
At a glance
- Originator Roche
- Class Antineoplastics; Small molecules
- Mechanism of Action Thymidylate synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 07 Mar 2007 Discontinued - Phase-III for Cancer in Japan (unspecified route)
- 09 Nov 2000 No-Development-Reported - Phase-III for Cancer in Japan (Unknown route)